Disseminated intravascular coagulation

Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006 Feb 21;4:4.Full text  Abstract

Taylor FB Jr, Toh CH, Hoots WK, et al; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327-30. Abstract

Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009 Apr;145(1):24-33.Full text  Abstract

1. Levi M, De Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med. 2004;36(1):41-9. Abstract

2. Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006 Feb 21;4:4.Full text  Abstract

3. Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021 Jan;113(1):45-57.Full text  Abstract

4. Taylor FB Jr, Toh CH, Hoots WK, et al; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327-30. Abstract

5. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med. 1995 Nov;23(11):1835-42. Abstract

6. Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016 Sep 28;14:42.Full text  Abstract

7. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018 Feb 22;131(8):845-54.Full text  Abstract

8. Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):8S-28S.Full text  Abstract

9. Costello RA, Nehring SM. Disseminated intravascular coagulation (DIC). StatPearls [Internet]. 2019 Nov 30.Full text  Abstract

10. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009 Apr;145(1):24-33.Full text  Abstract

11. Walborn A, Hoppensteadt D, Syed D, et al. Biomarker profile of sepsis-associated coagulopathy using biochip assay for inflammatory cytokines. Clin Appl Thromb Hemost. 2018 May;24(4):625-32.Full text  Abstract

12. Greenberg CS. The role of D-dimer testing in clinical hematology and oncology. Clin Adv Hematol Oncol. 2017 Aug;15(8):580-3. Abstract

13. Xu Y, Zhu R, Sun Y, et al. Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):127-32. Abstract

14. Chernecky CC, Berger BJ. Fibrinopeptide A. (FPA)-blood. In: Chernecky CC, Berger BJ, eds. Laboratory tests and diagnostic procedures. 6th ed. St Louis, MO: Elsevier Saunders; 2013:526-7.

15. Ota S, Wada H, Abe Y, et al. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis. Clin Appl Thromb Hemost. 2008 Jul;14(3):279-85.Full text  Abstract

16. Lemmer JH Jr, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2002 Feb;123(2):213-7.Full text  Abstract

17. Avvisati G, ten Cate JW, Buller HR, et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukemia. Lancet. 1989 Feb 15;2(8455):122-4. Abstract

18. Hagiwara A, Tanaka N, Uemura T, et al. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open. 2016 Dec 30;6(12):e012850.Full text  Abstract

19. Yasuda N, Goto K, Ohchi Y, et al. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation. J Crit Care. 2016 Dec;36:29-34. Abstract

20. Thachil J, Falanga A, Levi M, et al. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015 Jan 28;13(4):671-5.Full text  Abstract

21. Thachil J, Toh CH, Levi M, et al. The withdrawal of activated protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]. Br J Haematol. 2012 May;157(4):493-4.Full text  Abstract